Browse by Product Category
At Creative BioMart, we provide high-quality vaccine antigens for research and industry. Whether you need recombinant protein antigens, viral antigens, or specialized subunit vaccine components, our expert team ensures top-tier purity, consistency, and regulatory compliance.
Vaccines play a critical role in the prevention of infectious diseases by stimulating the immune system to recognize and attack pathogens. The fundamental component of any vaccine is the vaccine antigen, which serves as the primary trigger for an immune response. Vaccine antigens can be derived from bacteria, viruses or other infectious agents, and their composition varies depending on the type of vaccine.
Background of Vaccine Antigens
Vaccine antigens work by mimicking the structural or functional components of pathogens to stimulate the immune system to produce specific antibodies and memory cells. This ensures that when the body encounters the actual pathogen in the future, it can mount a rapid and effective immune response. The use of vaccine antigens has revolutionized global health, significantly reducing mortality from infectious diseases such as smallpox, polio, measles and influenza.
There are several types of vaccine antigens, including live attenuated pathogens, inactivated pathogens, subunit antigens, toxoids, and recombinant antigens. Each type has distinct advantages and challenges that affect its application in vaccine development. Among these, subunit vaccine antigens and viral antigens are two major categories that have received significant attention due to their safety, efficacy, and adaptability.
Subunit vaccines contain only specific fragments of a pathogen, such as proteins or polysaccharides, rather than the entire microorganism. These fragments are carefully selected to induce a robust immune response while minimizing potential side effects. Antigenic components used in subunit vaccines include surface proteins, viral envelope proteins or purified bacterial toxins.
One of the major advantages of subunit vaccines is their safety. Since they do not contain live pathogens, they cannot cause disease in immunocompromised individuals. In addition, by selecting well-characterized antigens, the immune response can be precisely targeted, reducing the risk of off-target effects.
Types of Subunit Vaccine Antigens
Subunit vaccines can be classified into different types based on their antigen composition:
- Protein Subunit Vaccines: Contain purified protein fragments from pathogens, often produced through recombinant DNA technology. Example: Hepatitis B vaccine.
- Polysaccharide Vaccines: Utilize bacterial polysaccharides to induce immunity, particularly against encapsulated bacteria. Example: Pneumococcal vaccine.
- Conjugate Vaccines: Combine polysaccharides with protein carriers to enhance immunogenicity, particularly in young children. Example: Haemophilus influenzae type B (Hib) vaccine.
- Toxoid Vaccines: Contain inactivated bacterial toxins (toxoids) to prevent toxin-mediated diseases. Example: Tetanus and diphtheria vaccines.
Viral antigens are components of viruses that elicit an immune response leading to the production of protective antibodies and memory cells. These antigens can be derived from whole viruses (either inactivated or live-attenuated) or from recombinant viral proteins. The selection of viral antigens depends on factors such as virus structure, immune evasion mechanisms and the most effective immunogenic regions.
Types of Viral Antigen-Based Vaccines
- Live Attenuated Viral Vaccines: Contain weakened forms of viruses that can replicate but do not cause disease. Example: Measles, mumps, and rubella (MMR) vaccine.
- Inactivated Viral Vaccines: Use chemically or heat-inactivated viruses to induce immunity without the risk of infection. Example: Inactivated polio vaccine (IPV).
- Recombinant Viral Vaccines: Use genetically engineered viral proteins to stimulate an immune response. Example: Recombinant influenza vaccine.
Hot Products
- SARS-CoV-2 Spike Protein (COVID-19 Vaccines): The spike (S) protein of the SARS-CoV-2 virus remains a central antigen for COVID-19 vaccines. Used in mRNA vaccines, protein subunit vaccines, and viral vector vaccines, the spike protein has proven highly effective in inducing immune responses. New variants continue to drive updates in vaccine formulations.
- RSV F Protein (Respiratory Syncytial Virus Vaccine): The fusion (F) protein of the Respiratory Syncytial Virus (RSV) is a key antigen in newly approved RSV vaccines. These vaccines offer protection against severe RSV infections in older adults and infants.
- Ebola Glycoprotein (GP) Antigen: The Ebola virus glycoprotein (GP) is the target antigen in vaccines. These vaccines have been crucial in controlling Ebola outbreaks in Africa.
- Influenza Hemagglutinin (HA) and Neuraminidase (NA) Proteins: Next-generation influenza vaccines focus on universal influenza antigens that target conserved regions of HA and NA to provide broader, longer-lasting protection against multiple strains.
- Tuberculosis Antigens (M72/AS01E and Other Candidates): After a century of reliance on the BCG vaccine, new candidates such as M72/AS01E (targeting the M72 fusion protein) are showing promise in providing enhanced protection against Mycobacterium tuberculosis.
Advantages of Our Vaccine Antigens
- Uncompromising Quality & Purity: We provide high-purity, highly characterized vaccine antigens that are manufactured under strict quality control. Our antigens undergo extensive validation, including endotoxin removal, sterility testing and functional assays to ensure optimal immunogenicity and batch-to-batch consistency.
- Broad Portfolio Covering Key Vaccine Targets: From viral and bacterial subunit antigens to recombinant proteins and inactivated whole pathogens, we offer a diverse selection of vaccine antigens tailored for infectious disease research, clinical trials, and large-scale vaccine production.
- Advanced Recombinant Technology for Scalable Production: Using state-of-the-art recombinant protein expression platforms (e.g., mammalian, bacterial, yeast, and insect cell systems), we deliver antigens with high yield, structural integrity, and post-translational modifications that mimic natural immune targets.
- Regulatory Compliance & GMP-Ready Capabilities: Our antigens are manufactured using GMP-compliant processes to ensure compliance with global regulatory requirements. We support preclinical and clinical vaccine development with comprehensive documentation for regulatory submissions.
- Reliable Supply & Scalability for Global Demand: We guarantee a stable, large-scale supply chain with global logistics support, ensuring that our customers receive high-quality vaccine antigens on time and in the required quantities—from research-scale to commercial production.
At Creative BioMart, we are more than just a supplier—we are your trusted partner in vaccine innovation. Let us help you accelerate your vaccine development with top-tier antigen solutions that meet the highest scientific and regulatory standards. Contact us today to explore how our vaccine antigens can enhance your immunization strategies!
